Karl Britt

Sustainable pharma needs better plastic

The biopharmaceutical industry faces a new and increasingly urgent materials challenge: how to preserve the performance, sterility, and scalability benefits of plastics while materially reducing their carbon footprint and creating credible pathways for material recovery. Plastics are deeply embedded in modern bioproces...